Načítá se...
Biologics use in Indian psoriasis patients
The biologics currently in use for psoriasis in India are etanercept, infliximab and recently introduced itolizumab and secukinumab. Biosimilars, expected to play a significant role in psoriasis management in future, have also been available for the last few years. Patients with psoriasis may be con...
Uloženo v:
| Vydáno v: | Indian Dermatol Online J |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Medknow Publications & Media Pvt Ltd
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5134162/ https://ncbi.nlm.nih.gov/pubmed/27990383 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2229-5178.193915 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|